Abstract Retinitis pigmentosa is a group of genetically transmitted disorders affecting 1 in 3000-8000 individual people worldwide ultimately affecting the quality of life. Retinitis pigmentosa is characterized as a heterogeneous genetic disorder which leads by progressive devolution of the retina leading to a progressive visual loss. It can occur in syndromic (with Usher syndrome and Bardet-Biedl syndrome) as well as non-syndromic nature. The mode of inheritance can be X-linked, autosomal dominant or autosomal recessive manner. To date 58 genes have been reported to associate with retinitis pigmentosa most of them are either expressed in photoreceptors or the retinal pigment epithelium. This review focuses on the disease mechanisms and genetics of retinitis pigmentosa. As retinitis pigmentosa is tremendously heterogeneous disorder expressing a multiplicity of mutations; different variations in the same gene might induce different disorders. In recent years, latest technologies including whole-exome sequencing contributing effectively to uncover the hidden genesis of retinitis pigmentosa by reporting new genetic mutations. In future, these advancements will help in better understanding the genotype-phenotype correlations of disease and likely to develop new therapies.
Introduction
More than 240 genetic mutations are involved in inherited retinal dystrophies which are an overlapping group of genetic and clinical heterogeneous disorders . Retinitis pigmentosa is a heterogeneous genetic disorder which is characterized by progressive devolution of the retina, affecting 1 in 3000-8000 people worldwide (Hamel 2006; Hartong et al. 2006) ; starting in the mid-fringe and advances towards the macula lutea and fovea. Symptoms include diminishing visual fields that lead to Kalnienk vision, ultimately leading to legal blindness or complete blindness (Hartong et al. 2006 ). Retinitis pigmentosa is also depicted as rod-cone dystrophy because of primarily degeneration of photoreceptor rods along with secondary degeneration of cones; eventually causing complete blindness. Photoreceptor rods are appeared to be more affected than cones. The rod-cone sequences elaborate why the night blindness is initially appeared in patients and in later life patients suffer from visual disability in periodic conditions (Hamel 2006) . Diseased photoreceptors face apoptosis (Marigo 2007) , which is resulted in reducing the thickness of the outer nuclear layer in the retina, and retinal pigments with abnormal structural changes are deposited in the fundus.
Clinical phenotypes may include, (1) abnormal absence of a-waves and b-waves in electroretinogram results, (2) reduced field vision. Symptoms appear in early teenage but severe visual impairment occurs by 40-50 years of age (Hamel 2006) . In a multicentre study, 999 patients (age 45 or older) were evaluated for visual acuity, carrying multiple genetic subtypes of retinitis pigmentosa revealed that 69% patients had visual acuity of 20/70 or better, 52% of 20/40 or better, 25% of 20/200 or worse and 0.5% had no light sensing in both eyes (Grover et al. 1999) . Genetic nature of retinitis pigmentosa is heterogeneous. In 1984, after first reported linkage of retinitis pigmentosa locus to a DNA marker on chromosome X (Bhattacharya et al. 1984) , currently mutation over 58 genes are known to cause retinitis (Table 1) .
In retinitis pigmentosa carriers, the nature of the disease can be non-syndromic (limited to the eye), or it can appear in syndromic nature. For example, in the case of syndromic nature of the disorder, patients carrying Usher syndrome express the combination of retinitis pigmentosa and hearing impairment (Mathur and Yang 2015) . Approximately 20-30% of patients carrying retinitis pigmentosa has an association with the non-ocular disorder, and would be categorized as carrying syndromic retinitis pigmentosa. For an instant, missense mutations of the BBS2 gene cause Bardet-Biedl syndrome (retinitis pigmentosa, obesity, mental retardation and polydactyl) or non-syndromic retinitis pigmentosa (Shevach et al. 2015) . Non-syndromic retinitis pigmentosa may be inherited as autosomal recessive, autosomal dominant digenic, X-linked and even mitochondrial patterns (Ferrari et al. 2011) . Overall percentage prevalence of non-syndromic and syndromic retinitis pigmentosa is shown in Table 2 . The most patronize types of syndromic retinitis pigmentosa are Usher syndrome and Bardet-Biedl syndrome (Ferrari et al. 2011) .
Genetic characterizations of retinitis pigments are complicated, so authorized genotype-phenotype correlation is impossible to define. In addition to numerosity of variations, as a matter of fact, different disorders may be caused by the different mutations in the same gene and same mutations can cause inter-familial and intra-familial phenotypic variability. For example, the vast majority of rhodopsin mutations depict a classical autosomal dominant pattern of inheritance, leading to retinitis pigmentosa. However, low numbers of mutations depict autosomal recessive patterns of inheritance (Berger et al. 2010) . Likewise, major X-linked recessive retinitis pigmentosa gene-RPGR-is linked with the mutations in male patients and no phenotypic male-to-male characteristics have ever been reported to transmit. The current review focuses on the genesis on the retinitis pigmentosa and how mutations lead to pathophysiological effects. For the accurate outcomes, mutations frequency of the genes will be evaluated that are associated with retinitis pigmentosa and how these mutations lead to retinal degradation; ultimately inducing retinitis pigmentosa.
Visual phototransduction
To better understand how the mutations in genes associated with retinitis pigmentosa influence the functions of proteins, the molecular basis of the visual phototransduction is needed to be understood. Visual phototransduction is a biological process through which light signals are converted into electrical signals in the light-sensitive cells(rod and cone photoreceptors) in the retina of the eye. The photoreceptors cells are the polarized type of neurons in the retina that is capable of phototransduction. Photoreceptors cells consist of a cell body, an inner segment, an outer segment and synaptic region. Inner segment is connected to the outer segment via cilium. The molecular machinery resides within the inner segment that is involved in the biosynthesis, membrane trafficking and the energy metabolism system. Outer segment is comprised of membranous discs circumvented by a plasma membrane. Over 90% of the total protein in the outer segment is rhodopsin. Vision begins via an apoprotein (opsins) and a chromophore (11-cis, derived from vitamin A) attached to the opsin by Schiff base bond. Isomerization of 11-cis retinal is induced via light absorption by rhodopsin protein to alltrans retinal, ultimately conformation of the opsin is changed, hence vision is initiated. In photoreceptor cells, all-trans retinal that is released from opsin is reduced to alltrans retinol and then moved to the pigmented layer of the retina. For the continuity of vision, in retinal pigment epithelium the 11-cis retinal is produced again from alltrans-retinol. This process is accomplished by 65 kDa isomerohydrolase expressed in retinal pigment epithelium known as RPE65 Redmond et al. 1998 ). Rhodopsin acts and triggers its GTP-binding protein, transducin, and canonical second-messenger signaling pathway is initiated with help of heterotetrameric phosphodiesterase 6 complexes.
Clinical description of retinitis pigmentosa
Retinitis pigmentosa develops over multiple decades; long lasting disease. Even so in extreme cases rapid development has also been shown. Retinitis pigmentosa can be handily classified into three stages; (1) the early stage, (2) the middle stage, and (3) the end stage.
Early stage
A major symptom of early stage retinitis pigmentosa is night blindness; may be appeared at different stages of life; from the first years of age, or during the second decade of life or even later. Patients carrying mild night blindness often ignore it, and it appears in teen ages, in dim light. At this stage, defects like peripheral visual field appear in dim light, but in daylights patients spent normal life and intensity of these defects are minimal. At the early stage of retinitis pigmentosa it is difficult to diagnose, especially when any kind of familial history is not available. Clinical examination of the fundus may appear normal (Fig. 1a) ; the optic disc is normal, no bone-spicule shaped pigment deposits are present, retinal arterioles fading is at a modest level, and color vision is normal. In the visual field tests under scotopic conditions, scotomas are revealed, but this test is usually carried out in mesopic conditions. Electroretinogram is a key test to better understand the prevailing conditions. Mostly, low amplitude b-waves are shown in results that dominate in scotopic conditions. However, if the retina partially defects, electroretinogram may appear normal.
Middle stage
Patients become cognizant of the loss of peripheral visual field in daylight conditions; patients miss hands in handshaking, during drive they cannot see side-coming cars. Night blindness is evident; with troubles to drive during night, walking at evening or in dark staircases. 
Genetic characterization of retinitis pigmentosa
Non-syndromic retinitis pigmentosa
Autosomal dominant retinitis pigmentosa So far mutations in 24 different genes have been associated with autosomal dominant retinitis pigmentosa (RetNet 2015) but only a few genes account for a relevant percentage of the retinitis pigmentosa cases, these include, RHO (26.5%), RPRH2 (5-9%), PRPF31 (8%) and RP1 (3-5%) (Ferrari et al. 2011) . Table 3 shows the genes that are associated with autosomal dominant retinitis pigmentosa.
PRPF31 (Pre-mRNA processing factor 31) Mutation in PRPF31 (Pre-mRNA splicing factor of 61 kDa) is currently proposed to play a vital role in autosomal dominant retinitis pigmentosa, inducing 1-8% cases of autosomal dominant retinitis pigmentosa (Audo et al. 2010a; Venturini et al. 2012 ). Apparently PRPF31 is one of the three pre-mRNA splicing factors inducing autosomal dominant retinitis pigmentosa, two other factors are PRPF3 (1% of all cases) and PRPF8 (3% of all cases). One of the unique characteristics of mutations in PRPF31 is the incomplete penetrance. Mode of inheritance may be complicated to determine if symptomless carriers have affected parents and children, because of that genetic counseling of family is hindered. Symptomatic patients have been reported to experience night blindness and loss of visual field in teenage, and are generally reported as blind, when they are in the 30 s. Comparison of haplotype analysis of asymptomatic and symptomatic patients reveals that both types inherit different wild-type allele. Wild-type allele with a high level of expression may adjust for the nonfunctional mutated allele, but wild-type allele with low expression is unable to reach the activity threshold level of required photoreceptor-specific PRPF31 Vithana et al. 2003) .
RP1 (retinitis pigmentosa 1) By positional cloning RP1 gene was first time reported by linkage testing in large autosomal dominant retinitis pigmentosa family southeastern Kentucky. Mutations in RP1 gene induce both dominant and recessive types of retinitis pigmentosa (Blanton et al. 1991; Field et al. 1982) . 240-kD retinal photoreceptor-specific protein is encoded by RP1 gene and the expression of RP1 in very prominent. Clinical diagnosis of patients carrying RP1 mutated gene shows reduced visual field diameters. Generally genetic disorders are thought to be caused by environmental factors, allelic heterogeneity and genetic variations, but for RP1 disorders, genetic variants are thought to important because of the severity of disorder variety reveals the patients with the same primary mutation.
RHO (rhodopsin)
The first component of visual transduction pathway is rhodopsin and when the light is absorbed by the rod cell of the retina, it is activated (Murray et al. 2009) . With more than 100 mutations, approximately 30-40% cases of autosomal dominant retinitis pigmentosa are induced due to mutations in RHO gene. Autosomal recessive retinitis pigmentosa and autosomal dominant congenital night blindness can also be induced by the mutations in RHO gene. Murray and colleagues reported the autosomal dominant retinitis pigmentosa case resulted from RHO gene mutation, which nominated a protein with no 6th and 7th transmembrane, including the 11-cis retinal binding site (Rosenfeld et al. 1992) . In a mouse model experiment carrying dominant retinitis pigmentosa, improved retinal function was achieved, following subretinal administration of recombinant are non-associated virus vectors containing RNAi-based suppressors (Chadderton et al. 2009 ). Latterly, restoration of visual function was achieved in P23H transgenic rats following subretinal administration of recombinant are non-associated virus vectors containing Bip/Grp78 gene (Gorbatyuk et al. 2010) . In spite of all knowledge in autosomal dominant retinitis pigmentosa induced by the RHO gene mutation, Perrault et al. (2004) , Janecke et al. (2004) therapeutical approaches did not proceed at the same pace.
PRPH2 (Peripherin 2)
The PRPH2 (Peripherin 2) gene, once recognized as RDS (retinal degeneration slow) gene containing 3 exons and encoded 346 amino acid protein (39-kDa integral membrane glycoprotein). The protein is reported at the outer segment disc of cone and rod photoreceptor, containing one intradiscal domain (D2) and four transmembrane domains (known as M1-M4). The protein in combination with another protein (ROM1) forms homotetrameric and heterotetrameric complexes and also forms a homo-oligomeric structure with itself (Loewen et al. 2001) . In 1991, PRPH2 mutations inducing retinitis pigmentosa were first time reported and cause about 5-9% of autosomal dominant retinitis pigmentosa cases. Mutation in PRPH2 gene and ROM1 gene has been observed to cause digenic retinitis pigmentosa (Dryja et al. 1997 ).
Autosomal recessive retinitis pigmentosa
For autosomal recessive retinitis pigmentosa, over 40 genes have been mapped (Table 4) and most of the genes are rare and cause 1% of fewer cases. Some genes like RP25, PDE6A, RPE65, and PDE6B have higher prevalence percentage up to 2-5% of all cases.
Rp25 Mutations that are rare to another geographical region can be the common reason to cause autosomal recessive retinitis pigmentosa in particular populations, for example the RP25 locus has been reported for causing 10-20% of autosomal recessive retinitis pigmentosa cases in Spanish populations (Barragán et al. 2008 ).
PDE6 (PDE6A, PDE6B, PDE6G) One a, b and two c subunits are important parts of the PDE6 complex; which encode a protein that has a vital function in rod photoreceptor visual phototransduction. Intracellular cGMP level is maintained by the complex by the hydrolyzing process of cGMP, due to G protein light activation (Tsang et al. 1998) .
In retinitis pigmentosa case, processes are unknown that induce rod photoreceptor death, but it is thought that low PDE6 activity may lead to rode-cone devolution. For proper photoreceptor function every subunit of PDE6 complex is necessary, in fact for autosomal recessive retinitis pigmentosa, mutations in PDE6A and PDE6B genes are second most familiar cause for inducing disease. Visual loss is the main risk for heterozygous carriers, carrying mutations in PDE6 gene, when PDE6 is inhibited using drugs like revatio, cialis, or levitra (Tsang et al. 2008) . Latterly PDE6G gene is reported with a mutation, causing autosomal recessive retinitis pigmentosa (early onset) (Dvir et al. 2010 ).
Rpe65 RPE65 (an enzyme by which all-trans-retinyl esters in hydrolyzed into 11-cis-retinol) is vital for the reformation of the visual pigments essential for rod-mediated and cone-mediated vision and it is expressed in the pigmented layer of the retina. RPE65 gene has been reported for approximately 60 mutations and causing recessive retinitis pigmentosa (2%) and leber congenital amaurosis (16%) (Cai et al. 2009 ). In three pre-clinical experiments, patients with leber congenital amaurosis were injected with adeno-associated viral vectors comprising the human RPE65 cDNA. Modest level improvements were achieved in visual acuity (Bainbridge et al. 2008; Cideciyan et al. 2008; Maguire et al. 2008 ).
X-linked retinitis pigmentosa
X-linked retinitis pigmentosa patients exhibit severe phenotypes in early phases of disorder development and account approximately 10-15% of all retinitis pigmentosa cases. In some cases, deafness, abnormal sperm development and defective respiratory tract were noticed (Veltel and Wittinghofer 2009) . Only two gene loci (RP2 and RP3) have been recognized so far out of six mapped gene loci (RP2, RP6, RP23, RP24, RP34 and RPGR) on X-chromosome (Table 5) . More than 70% patients carrying X-linked retinitis pigmentosa have mutations in RP3 gene, and RP3 gene product is located on an external segment of rod photoreceptor (Vervoort et al. 2000) . Approximately 10-15% patients carry X-linked retinitis pigmentosa due to mutations in RP2 gene (Veltel and Wittinghofer 2009) . 
Syndromic retinitis pigmentosa
Retinitis pigmentosa is generally an isolated problem; the only eye is affected, but in other various rare cases retinitis pigmentosa is also linked to other disorders. Examples may include Usher syndrome, refsum syndrome, Bardet-Biedl syndrome.
Usher syndrome
Usher syndrome is an autosomal recessive disorder, in which retinitis pigmentosa, hearing impairment and sometimes vestibular dysfunction are associated. Deafblindness is the most common disorder due to this syndrome. Prevalence is 1:12,000-1:30,000 individuals in different populations. 10-30% of autosomal recessive retinitis pigmentosa cases are caused due to usher syndrome (Millan et al. 2011) . In clinical manners, usher syndrome is separated into three types, (1) usher type I (severe form), (2) usher type II (moderate to severe form) and (3) usher type III. To date 12 genes have been reported for usher syndrome; 7 genes for usher type I, 3 genes for usher type II and 2 genes for usher type III (Table 6 ).
Bardet-Biedl syndrome
Bardet-Biedl syndrome is defined a recessive inherited disorder with symptoms of obesity (72%), learning difficulties, abnormalities of the fingers/toes, kidney disease, rod-cone dystrophy ([90%) and renal abnormalities. Bardet-Biedl syndrome affects 1: 120,000 Caucasians, but high prevalence (1:13,000) has been reported in a population of north Atlantic (Moore et al. 2005) and within the Bedouins (1:13500-1:16900) (Teebi 1994) . Children carry BardetBiedl syndrome has a poor visual prognosis. Night blindness is usually apparent by age 7 to 8 years (Heon et al. 2005; Azari et al. 2006 ). To date, 21 genes have been associated with Bardet-Biedl syndrome (Table 7) .
Whole-exome sequencing as an effective tool in clinical and symptomatic genetics Advancement in DNA sequencing has become the most efficient resources for basic biological and clinical research, and has been applied in various fields such as biological systematics, diagnostics, biotechnology, parental testing and forensic identifications. The combination Li et al. (2010a) of chain termination sequence (Mullis et al. 1992 ) and polymerase chain reaction (Sanger et al. 1977 ) established many of the prominent events such as the completion of the Human Genome Project that provided barely ample references to study the genetic modifications in associated phenotypes (Venter 2003; Sachidanandam et al. 2001) .
Recently new technologies for whole-genome sequencing and whole-exome sequencing replaced the traditional methods with low-cost sequencing cost per exome/genome. These advanced next-generation sequencing technologies, revolutionized the clinical structure to improve human health, although there are many problems to be addressed like, the high cost of the procedure, user-friendly software to analysis raw genetics and sequence data and the ethical issues that are related to gathering genetic data.
Role of whole-exome sequencing in human genetic disorders
According to OMIM Statistics presently, over 6000 presumptively single gene disorders have been reported, but the molecular basis of nearly two-third of disorders has not been described. Finding phenotypic variants and causative genes help in understanding the pathogenic mechanism of the prevailing disorder. In patients or small families with newly identified variants, genetic diagnosis is difficult to conceivable just on the basis of variant finding. It is much difficult to find more patients if the disorder is very rare. Recently reported variants are needed to validate for having pathologic effect with the help of functional experiments; biochemical confirmatory experiments are allowed to execute if the mutated gene has delimitated function in a well-known pathway associated with the disease. Novel genes identification causing rare single gene disorders is important to apprehend the biological pathways causing disorder as well as therapeutic management. Recent studies emphases that whole-exome sequencing is a powerful technique to find out casual genes responsible for Mendelian disorders (Rabbani et al. 2012 ); Fig. 2 shows the combination of exome sequencing and filtering strategy is helpful to distinguish the fundamental gene causing Mendelian disorders.
Heterogeneous single gene phenotypes
There are many genetically heterogeneous disorders like retinitis pigmentosa, intellectual disability, hereditary hearing impairment, and autistic spectrum disorder. Fiskerstrand et al. (2010) Whole-exome sequencing has successfully resulted to distinguish various genes causing retinal disorders. Table 8 shows the role of whole-exome sequencing in identifying de novo genes in retinal disorders.
Future concerns
In near future it is hoped that, new strategies will be introduced for molecular diagnosis of retinitis pigmentosa for clinical practices, and disease inducing variations in genes will be discovered. But for this hope to come true, specific conditions are needed to meet; (1) All diseasecausing variations in genes should possibly be reported, (2) techniques for molecular diagnosis should be low-cost, authentic, quick and widely available, (3) clinical should have the ability to understand the molecular information provided by a molecular diagnosis of disease. Currently reliable technologies are available and new technologies are rising that enhance the chances to report new mutations in individuals. For known mutations detection, currently array-based diagnostic technology is available for several retinal diseases. Next-generation sequencing is allowing the researchers to identify disease-causing variants and to Liu et al. (2015) Recessive oculoauricular syndrome 4p16.1 HMX1 Gillespie et al. (2015) Recessive microcephaly, growth failure and retinopathy 4q28. Khateb et al. (2014) 
